相关实验视频

Updated: Jun 9, 2025

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Published on: April 18, 2019

评论:了解IARC的PFOA和PFOS致癌性评估

Nicholas L Drury¹, Robyn L Prueitt², Barbara D Beck¹

¹One Beacon St., 17th Floor, Boston, MA, 02108, USA.

Regulatory toxicology and pharmacology : RTP

|October 21, 2024

概括

国际癌症研究机构 (IARC) 可能夸大了将 perfluorooctanoic acid (PFOA) 和 perfluorooctanesulfonic acid (PFOS) 分类为致癌的证据. 一项审查表明,对于这些持久性有机污染物,流行病学和动物研究数据很弱和不一致.

科学领域:

环境健康环境健康
毒理学毒理学毒理学
致癌的发生是致癌的产生.

背景情况:

国际癌症研究机构 (IARC) 最近分类 perfluorooctanoic 酸 (PFOA) 和 perfluorooctanesulfonic 酸 (PFOS) 分别为对人类致癌性 (组1) 和可能致癌性 (组2B).
这些分类是基于对流行病学,实验动物和机械学证据的广泛审查.

研究的目的:

批判性地评估IARC对PFOA和PFOS的致癌性分类.
评估IARC重新评估过程中使用的证据的强度和一致性.

主要方法:

对调查人类暴露于PFOA和PFOS的流行病学研究的审查和分析.
评估实验性动物研究报告PFOA和PFOS暴露后瘤发生率.
评估IARC对致癌物的关键特征 (KCC) 框架的应用.

主要成果:

流行病学研究显示,PFOA/PFOS暴露与癌症之间存在微弱且不一致的关联.
动物研究中的瘤发病率通常是由良性腺瘤驱动的,这质疑了这些发现的意义.
IARC使用KCCs方法可能没有充分考虑机械学数据的质量,外部有效性和人类相关性.

结论:

国际癌症研究中心工作组可能夸大了PFOA和PFOS致癌性的证据.
建议对机理学证据进行更严格的评估,重点关注可信性和人类相关性,而不是检查列表方法.
需要进一步的研究和批判性评估,以准确确定PFOA和PFOS的致癌潜力.

关键词:

癌症癌症癌症癌症致癌机制的致癌机制流行病学流行病学实验动物实验动物危险分类的危险分类 perfluorooctanesulfonic 酸 (PFOS) 是一种含有多酸的化合物.perfluorooctanoic 酸 (PFOA) 是一种含有多酸的化合物.

更多相关视频

Investigating Long-Distance Transport of Perfluoroalkyl Acids in Wheat via a Split-Root Exposure Technique

Investigating Long-Distance Transport of Perfluoroalkyl Acids in Wheat via a Split-Root Exposure Technique

Published on: September 28, 2022

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

相关概念视频

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...